Latest SHARES Magazine is recommending MBP/MBPO among its top ten stock picks for the year.
Extract from article:
"Why choose Metabolic as the biotech stock of 2003? Metabolic will be conducting its pivotal Phase IIb trial for its anti-obesity drug AOD9604. It's a crucial step for Metabolic, and if successful, the company will be deservedly catapulted into a powerful bargaining position with potential pharmaceutical licensing partners."
Link to full article:
http://www.sharesmag.com.au/stories2/20030201/17600.asp
I have been following Metabolic for years and timing and patience has paid off. They recently concluded the latest human trials and the results are due next month, so it's time to get on board before the results are released.
shares mag top ten pick for 2003
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)